Paul K. Wotton

2008

In 2008, Paul K. Wotton earned a total compensation of $641.8K as Chief Executive Officer at Antares Pharma.

Compensation breakdown

Non-Equity Incentive Plan$83,407
Option Awards$318,021
Salary$152,888
Stock Awards$80,000
Other$7,445
Total$641,761

Wotton received $318K in option awards, accounting for 50% of the total pay in 2008.

Wotton also received $83.4K in non-equity incentive plan, $152.9K in salary, $80K in stock awards and $7.4K in other compensation.

Rankings

In 2008, Paul K. Wotton's compensation ranked 5,733rd out of 9,135 executives tracked by ExecPay. In other words, Wotton earned more than 37.2% of executives.

ClassificationRankingPercentile
All
5,733
out of 9,135
37th
Division
Manufacturing
2,097
out of 3,436
39th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
296
out of 517
43rd
Industry group
Surgical, Medical, And Dental Instruments And Supplies
152
out of 272
44th
Industry
Surgical and Medical Instruments and Apparatus
101
out of 179
44th
Source: SEC filing on April 15, 2011.

Wotton's colleagues

We found four more compensation records of executives who worked with Paul K. Wotton at Antares Pharma in 2008.

2008

Jack Stover

Antares Pharma

Chief Executive Officer

2008

Dario Carrara

Antares Pharma

Managing Director, Pharmaceutical Group

2008

Robert Apple

Antares Pharma

Chief Financial Officer

2008

Peter Sadowski

Antares Pharma

Senior Vice President and Managing Director, Parenteral Products Division

You may also like